Adage Capital Partners Gp, L.L.C. Exact Sciences Corp Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Exact Sciences Corp stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 378,200 shares of EXAS stock, worth $18.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
378,200Holding current value
$18.8 Million% of portfolio
0.04%Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
671Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$870 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$845 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$599 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$598 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$309 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.78B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...